Literature DB >> 12349942

Tumor-associated macrophages: a molecular perspective.

Antonio Sica1, Alessandra Saccani, Alberto Mantovani.   

Abstract

The "macrophage balance hypothesis" was proposed in the early 1990s to depict the complex relationship that tumor-associated macrophages (TAM) have with the neoplastic cells of the tumor. TAM represent a prominent component of the mononuclear leukocyte population of solid tumors, which displays an ambivalent relationship with tumors. They originate in the circulation and are recruited to the tumor site by tumor-derived attractants such as chemokines and interact with the tumor cells and preferentially localize at the tumor-host tissue interface, in regions often associated with low oxygen tensions. The tumor microenvironment, including cytokines and hypoxia, regulates the localization and function of TAM. Emerging evidence starts to define the molecular basis for the peculiar functional phenotype of TAM and identifies possible therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12349942     DOI: 10.1016/s1567-5769(02)00064-4

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  30 in total

Review 1.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

2.  Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70.

Authors:  Ruifang Zheng; George P Studzinski
Journal:  Leuk Lymphoma       Date:  2016-10-17

3.  PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.

Authors:  Ning Li; Junfang Qin; Lan Lan; Hongyao Zhang; Fang Liu; Zhaozhen Wu; Hong Ni; Yue Wang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma.

Authors:  Michael G Alexandrakis; Nektaria Goulidaki; Constantina A Pappa; Anna Boula; Fotios Psarakis; Ioannis Neonakis; George Tsirakis
Journal:  Pathol Oncol Res       Date:  2015-03-06       Impact factor: 3.201

5.  Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.

Authors:  Lyudmila Burdelya; Maciej Kujawski; Guilian Niu; Bin Zhong; Tianhong Wang; Shumin Zhang; Marcin Kortylewski; Kenneth Shain; Heidi Kay; Julie Djeu; William Dalton; Drew Pardoll; Sheng Wei; Hua Yu
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

Review 6.  Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Authors:  Umar Mehraj; Hina Qayoom; Manzoor A Mir
Journal:  Breast Cancer       Date:  2021-03-04       Impact factor: 4.239

Review 7.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

Review 8.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 9.  Macrophages and pancreatic ductal adenocarcinoma.

Authors:  Aida Habtezion; Mouad Edderkaoui; Stephen J Pandol
Journal:  Cancer Lett       Date:  2015-12-18       Impact factor: 8.679

Review 10.  Targeting tumor-associated macrophages by anti-tumor Chinese materia medica.

Authors:  Wei-Ling Pu; Li-Kang Sun; Xiu-Mei Gao; Curzio Rüegg; Muriel Cuendet; Micheal O Hottiger; Kun Zhou; Lin Miao; Yun-Sha Zhang; Margaret Gebauer
Journal:  Chin J Integr Med       Date:  2017-10-08       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.